Cecil B. Pickett, Ph.D.
President
Schering-Plough Research Institute
|
2005 Researcher Category
Cecil
B. Pickett, Ph.D., is senior vice president of Schering-Plough
Corporation and president, Schering-Plough
Research Institute, the pharmaceutical research arm of
Schering-Plough Corporation, a global science-based health care
company with leading prescription, consumer and animal health products.
Through internal research and collaborations with partners,
Schering-Plough discovers, develops, manufactures and markets advanced
drug therapies to meet important medical needs.
Schering-Plough’s vision is to earn the trust of the
physicians, patients and customers served by its more than 30,000 people
around the world. This
company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
Dr. Pickett is responsible for all aspects of Schering-Plough
Research Institute.
Dr.
Pickett was appointed to his present position in March 2002.
He joined Schering-Plough Research Institute in 1993, as
executive vice president, discovery research, responsible for the
planning, management and oversight of Schering-Plough’s new drug
discovery programs across all therapeutic areas, and for coordinating
those programs with other research and commercial components in the
Company.
Dr.
Pickett came to Schering-Plough Research Institute from Merck Research
Laboratories, Montreal, Canada, and West Point, Pa., where he served as
senior vice president, basic research.
During his 15-year employ at Merck & Co., Dr. Pickett held
various positions of increasing responsibility, including research
fellow, biochemical regulation; associate director, department of
molecular pharmacology and biochemistry; director, department of
molecular pharmacology and biochemistry; executive director of research
at the Merck Frosst Center for Therapeutic Research, Montreal; and vice
president of the Center.
Dr.
Pickett received his B.S. degree in biology from California State
University, Hayward, Calif., and his Ph.D. degree in cell biology from
the University of California, Los Angeles (UCLA).
Dr.
Pickett has been published extensively in leading research journals and
has been a frequent speaker at scientific symposia and conferences.
He has received several major academic awards, appointments and
fellowships and serves on a number of scientific committees and
editorial boards of medical journals and research organizations.
His awards and honors include the UCLA Alumni Association Award
for Scholarly Achievement and Academic Distinction (1976); Macy Scholar,
Marine Biological Laboratories, Woods Hole, Mass. (1978); first Robert
A. Scala Award and Lectureship in Toxicology of Rutgers University and
the University of Medicine and Dentistry of New Jersey (1993);
Distinguished Lecturer, Jonsson Comprehensive Cancer Center, UCLA
(1995); and the CIIT Centers for Health Research Founders’ Award
(2001).
Dr.
Pickett has served as a member of the U.S. Food and Drug Administration
(FDA) Science Board, the Advisory Committee to the Director of the
National Institutes of Health and The National Cancer Policy Board of
the Institute of Medicine. He
currently serves as a member of the National Academies Committee on
Science, Engineering and Public Policy and a member of the Institute of
Medicine Forum on Drug Discovery, Development and Translation. He
was elected to the Institute of Medicine of the National Academy of
Sciences in 1993 and also is a member of The American Society for Cell
Biology, American Society of Biochemistry & Molecular Biology,
American Association for Cancer Research, and American Association for
the Advancement of Science.
|
